Top Pet Companies (419)

Customer Loyalty & Retention: Autoship accounts for the vast majority of sales (over four-fifths) and is growing faster than total revenue, indicating a sticky, recurring base and higher retention. Evidence includes Autoship representing ~83% of FY2025 net sales and ~84.6% in Q2 FY2026 with high single‑digit to double‑digit growth.

Profitability: Operating metrics show expanding earnings power, with adjusted EBITDA up materially and margins improving alongside strong free cash flow. Observations include FY2025 adjusted EBITDA growth of ~26% with margin expansion and additional year‑over‑year gains reported in 1H FY2026.

Strong Market Position & Advantage: Chewy is characterized as the largest U.S. pet e‑tailer and a leading online pet‑supplies platform by GMV and digital presence, underpinning durable scale advantages. Multiple summaries highlight leadership in online pet retail, substantial Autoship penetration, and strong digital search share versus specialty peers.

Strong Revenue Growth: Available evidence indicates revenue scaled from roughly $800 million in 2023 to an estimated $1.2 billion annualized in 2024. The longer-term trajectory shows steady gains from 2017 onward, with scale signals like surpassing 1 billion meals delivered.

Profitability: Reporting describes more than $10 million in monthly profit, indicating a shift from pure growth to profitable scaling. This supports the view that the company can sustain operations while continuing to invest.

Market Expansion: Operations have broadened beyond DTC through personalized meal plans on Walmart.com and expansion via the Woof acquisition into canine wellness products. Continued veterinary research investment and substantial TV ad spend point to active reach and capability expansion.

Market Expansion: Adoption appears to have increased from 19,000+ hospitals in June 2023 to 23,000+ currently, indicating continued penetration of the U.S. veterinary market. The platform is also described as powering purchasing infrastructure for the majority of several practice types nationwide.

Product Line Growth: The offering has expanded from a price-comparison tool into a broader procurement ecosystem spanning distributors, manufacturers, and diagnostic labs, with a catalog covering 99.9% of products veterinarians use. This evolution points to a shift toward comprehensive procurement infrastructure rather than a single-point solution.

Strong Market Position & Advantage: A 23,000+ hospital installed base and a supplier-side marketplace marketed as access to 23,000+ clinics suggest reinforcing network effects. Monetization on the supplier/manufacturer side and corporate capabilities further underscore centrality in the purchasing workflow.

Market Expansion: The brands are available via direct-to-consumer channels as well as independent pet stores and major retailers like Petco, Chewy, and Amazon, with visibility reinforced by participation at a major industry trade show. This points to widening distribution beyond a DTC base.

Product Line Growth: The portfolio now spans three brands—Dr. Marty Pets, Badlands Ranch, and Ultimate Pet Nutrition—with Badlands Ranch launched in 2022. This indicates an expanding multi-brand platform rather than reliance on a single label.

Investor Backing & Capital Strength: Reuters reported preparations for a potential IPO that could value the company at over $1 billion, with Morgan Stanley and Barclays involved. This is a notable capital‑markets signal of scale and financing access.

Strong Revenue Growth: Revenue is described as hitting $100 million in 2025 and reaching a $200 million annualized run rate in 2026, with growth reported at more than 70% year over year. Customer additions numbering in the hundreds of thousands in 2026 further indicate accelerating top-line momentum.

Profitability: Profitability is cited alongside the rapid revenue expansion, indicating growth that is not being driven solely by losses. This pairing of scale and earnings suggests improving unit economics as the company scales.

Product Line Growth: The PupGum dental-chew brand reportedly surpassed $10 million in annual recurring revenue within seven months, and the portfolio has broadened with UnKibble and supplements. Such extensions point to new revenue contributors beyond the core fresh meals.

Market Expansion: Ongoing openings and upgrades—such as a new 23,000-square-foot specialty hospital in Dallas, a rebuilt and expanded Sanibel hospital, and continued acquisitions—indicate an expanding footprint. Announced plans include a nationwide rollout of new locations in urgent care alongside additional specialty and emergency capabilities.

Product Line Growth: Service-line additions are visible in areas like urgent care, surgery, neurology, and planned 24/7 emergency coverage at new facilities. These moves point to growth in higher-acuity offerings beyond general practice.

Strong Market Position & Advantage: The organization is repeatedly characterized as a leader with 1,000+ hospitals and millions of pets served annually, signaling substantial scale and reach. Its specialized hospitals, board-certified doctors, and national network reinforce a durable competitive position.

Profitability: Operating income and margins expanded in Q1 2026, and adjusted EBITDA is guided above the prior year, signaling improving earnings quality. Management highlights continued margin progress alongside reaffirmed full‑year EBITDA guidance.

Cost & Operational Efficiency: Store fleet optimization and a defined cost‑savings program, together with gross margin improvement, indicate disciplined execution and balance‑sheet repair. Leverage reduction and operational improvements support a more resilient operating model.

Diversified Revenue Streams: Differentiated services are the fastest‑growing segment with a rising sales mix, while consumables have improved, shifting the portfolio toward higher‑margin areas. Services and premium consumables collectively represent a substantial portion of sales, deepening customer relationships.

Strong Market Position & Advantage: iHerb is positioned as a top-tier specialist in online health and wellness retail, including being ranked highly among online Health & Beauty retailers and described as a leader among pure-play, cross-border platforms.

Strong Revenue Growth: iHerb reports record 2024 performance with all-time-high net sales and year-over-year growth, alongside large order volume that indicates continued scale-up.

Customer Loyalty & Retention: Repeat purchasing is highlighted as a material contributor to demand, with orders from returning customers cited as a sign of strong loyalty and retention dynamics.